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A case report: Familial glucocorticoid deficiency
associated with familial focal segmental
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Nanik Ram*, Ali Asghar and Najmul Islam
Abstract
Background: Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by
isolated glucocorticoid deficiency in the presence of normal plasma renin and aldosterone level. Focal segmental
glomerulosclerosis (FSGS) is a form of glomerular disease associated with proteinuria and nephritic syndrome. This
is the first case of familial glucocorticoid deficiency associated with familial focal segmental glomerulosclerosis.
Case presentation: An eight month old boy presented with increased genital pigmentation. Initial investigation
revealed that he was glucocorticoid deficient and was started on hydrocortisone and fludrocortisone with a
diagnosis of primary adrenal insufficiency. Later fludrocortisone was withdrawn and he was diagnosed to have
isolated glucocorticoid deficiency. He later developed focal segmental glomerulosclerosis for which he underwent
renal transplantation at the age of five years. Now at the age of twelve years, this boy is doing well on
hydrocortisone treatment. His two siblings and a first degree cousin also had isolated glucocorticoid deficiency.
One of the above two siblings died due to renal failure secondary to focal segmental glomerulosclerosis.
Conclusion: Patients with familial glucocorticoid deficiency should be carefully followed for development of
features of nephrotic syndrome.
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Background
Familial glucocorticoid deficiency (FGD) is a rare auto-
somal recessive disorder characterized by isolated gluco-
corticoid deficiency in the presence of normal plasma
renin and aldosterone level resulting from ACTH resist-
ance [1]. Focal segmental glomerulosclerosis (FSGS) is a
form of glomerular disease associated with proteinuria
and nephritic syndrome [2]. Secondary FSGS is reported
with endocrine disorders like Addison’s disease [3],
cushing disease [4], acromegaly [5] and panhypopituar-
ism [6].
We present here a rare case of a patient with FGD
associated with familial FSGS. To our knowledge, there
are no case reports of such patients.
Case presentation
An eight month old boy brought by parents in clinic
with complaint of increased genital pigmentation. Initial
investigations showed low serum cortisol with an ACTH
level 1250 pg/ml (6–48 pg/ml). He was started on ster-
oid replacement of hydrocortisone and fludrocortisones
with the diagnosis of primary adrenal insufficiency. He
was doing well and repeated laboratory results revealed
ACTH level of 7 pg/ml and 14.7 pg/ml on two occasions
after steroid replacement. Later the diagnosis of primary
adrenal insufficiency was re-visited based on laboratory
results, when off fludrocortisone and hydrocortisone his
serum cortisol decreased with highly elevated ACTH
level but normal electrolytes and plasma rennin activity.
His diagnosis was changed to isolated glucocorticoid
deficiency.
At age of two and half years he developed generalized
body swelling and facial puffiness. His baseline labs
showed a serum creatinine of 0.5 mg/dl, serum sodium
of 139 meq/L and a serum potassium of 4.0 meq/L.
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Endocrine workup revealed a ACTH level of 1179 pg/
ml, cortisol of 6.15 μg/dl (2.8 to 23 μg/dL) and plasma
renin activity of 3.35 ng/ml/hr (2.35 to 37 ng/mL/hour).
The question was raised about compliance to medicine.
Further labs were done for possible nephrotic syndrome
based on his clinical presentation which showed a
24 hour urinary protein result of 3679 mg/24 hour with
serum total protein of 3.6 g/dl, albumin of 0.9 gm/dl and
a globulin level of 2.7 gm/dl. Steroid dose was increased
but proteinuria did not respond and later immunosup-
pressive therapy was added.
Renal biopsy was undertaken and histopathology
showed single core of renal tissue with up to 12 glom-
meruli. Of these four were totally sclerosed with reactive
epithelial proliferation. Three showed segmental scler-
osis, while five of them showed minor changes. There
was no vasculopathy but tiny patches of mild tubular at-
rophy and interstitial sclerosis were seen. Immunoflores-
cense done on frozen tissue showed granular membrane
and mesangial positivity of IgM, weak positivity of C3
andC1q in the same distribution as IgM while IgG
and IgA were negative. In conclusion, light microscopy
and IMF features were suggestive of focal segmental
glomerulosclerosis.
Renal functions rapidly deteriorated and his serum
creatinine reached a level of 4.9 mg/dl. He progressed to
end stage renal disease (ESRD) within a year of diagnosis
and was started on renal replacement therapy. He was
on hemodialysis for one year and later received living
related (uncle was donor) renal transplant at the age of
five years. He is doing well after transplant and his
ACTH level is 1.4pmol/L now on steroid replacement.
The patient’s elder brother had the same presentation
of increased genital pigmentation. He was diagnosed to
have primary adrenal insufficiency initially. Hydrocorti-
sone and fludrocortisone was started which he took for
around 7–8 years. His diagnosis was reviewed later in
view of low serum cortisol, high ACTH level with nor-
mal plasma rennin activity and electrolytes when he was
off medicines. The diagnosis was changed to isolated
glucocorticoid deficiency. Currently he is on hydrocorti-
sone replacement for the last 8 years without any prob-
lem with recent ACTH level within normal range. His
kidney functions test and urine detail report are normal.
His younger brother also had same problem of isolated
glucocorticoid deficiency, and he was on steroid replace-
ment. He also later developed nephrotic syndrome with
biopsy proven focal segmental glomerulosclerosis. He ul-
timately received renal replacement therapy but died at
the age of four years, before he could undergo renal
transplantation.
Patient’s mother also noticed same increased pigmen-
tation on genitals of her nephew; his lab workup was
consistent with isolated glucocorticoid deficiency and
was started on steroid replacement. He is now 3 years of
age with no evidence of nephrotic syndrome so far.
Patient’s family is not recalling any such type of illness
history in their predecessors, although there is strong
history of consanguineous marriages in the family
(Figure 1).
In view of patient and siblings clinical presentation
with low serum cortisol and high ACTH level with nor-
mal plasma renin activity, biopsy proven FSGS in both
of them and consanguineous marriages, diagnosis of fa-
milial glucocorticoid deficiency associated with familial
focal segmental glomerulosclerosis has been made.
Discussion
FGD typically presents between the neonatal period and
early childhood with hyper pigmentation, hypoglycemia,
failure to thrive, recurrent infections and seizures due to
hypoglycemia. All these symptoms and sign are related
to either high ACTH or low plasma cortisol levels.
There could be a family history of another affected
member and/or consanguineous marriage [7,8]. Our pa-
tient, his siblings and cousin presented with hyper pig-
mentation, but none of the other classical presenting
feature. The relatives come from a family with a history
of cousin marriages.
This disorder is caused by mutation in one of four ge-
nes. ACTH receptor [melanocortin 2 receptor (MC2R)],
its accessory protein [melanocortin 2 receptor accessory
protein (MRAP)] or STAR, all these are involved in ACTH
signaling-steroidogenic pathway. Recently meimaridou
et al. [9] found mutations in [nicotinamide nucleotide
transhydrogenase (NNT)] an antioxidant defense gene
responsible for FGD. NNT gene encodes an integral protein
Figure 1 Pedigree diagram. Squares indicate males and circles
females. White symbols show unaffected individuals; black symbols
show individuals diagnosed with Isolated familial glucocorticoid
defeciency FGD; diagonal stripes, individuals diagnosed with focal
segmental glomerulosclerosis FSGS; and combined black and
diagonal stripes, individuals diagnosed with FGD-FSGS. Filled arrow
indicates proband. A double line indicates consanguine marriage. A
diagonal black line marks deceased subject.
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of the inner mitochondrial membrane which appears to be
of primary importance for reactive oxygen species ROS
detoxification in adrenocortical cells. There is impaired
adrenal steroidogenesis due to this defective oxidative stress
response. These genetic defects account for 40–45% of
cases only [10]. In present case genetic testing has not been
done due to non-availability of DNA analysis in Pakistan
for these gene mutations. The mainstay of treatment is
glucocorticoid replacement.
FSGS is a major cause of ESRD as it is responsible for
about 20% of underlying pathology in children with
ESRD. FSGS is usually sporadic in origin. Walker R et al.
reported first autosomal dominant familial FSGS [11]. In
a study by Conlon PJ et al. [12], they identified 60 fam-
ilies with familial FSGS with vertical mode of transmis-
sion that suggested a genetic link. They described FSGS
as autosomal dominant when multiple generations were
affected; autosomal recessive when single generation was
affected. They observed more aggressive disease and
earlier presentation in families with single generation
involvement, as in our present case family.
Yamada S et al. [13] reported a case of FSGS with iso-
lated ACTH deficiency and reversible hypothyroidism.
In this case moderate proteinuria and thyroid function
improved after steroid replacement. Arrizabalaga et al.
[3] reported two cases of FSGS with Addison’s disease in
which proteinuria were resolved after steroid and min-
eralocorticoid replacement. Contrary to above in our
case proteinuria and renal functions in fact worsened
after steroid therapy through an unknown mechanism.
There are reports of multiple family members being
affected by FSGS in association with other hereditary
disorders like Charcot-Marie-Tooth disease [14], Laur-
ence Moon Biedl syndrome [15], Craniomandibular Der-
matodysostosis [16].
In our case the reported association is less likely to be
a coincidence, since two of three siblings have both con-
ditions. To date there is no report of multiple family
members being affected by FGD and FSGS. To know the
link between familial FGD and familial FSGS genetic
studies are needed.
Conclusion
Neonates and children with the diagnosis of primary
adrenal insufficiency in the presence of normal min-
eralocorticoid activity should be evaluated for isolated
glucocorticoid deficiency. Family counseling of such
patients is important for avoiding consanguineous mar-
riages to decrease the chances of FGD, particularly in
the case of autosomal recessive transmission. Because of
the association of FGD with FSGS as shown by us, any
patient with FGD should be carefully followed for devel-
opment of features of nephrotic syndrome.
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